Physician profile
William Coleman
NPI 1760404792
$2,564.03
in general payments reported to CMS, 2019-2025
19 companies · $265 in 2025
The $265 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $681 · 2020: $352 · 2021: $141 · 2022: $519 · 2023: $376 · 2024: $230 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $871.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $579.36 | 2021-2025 | Tremfya |
| Abbvie INC. | $498.64 | 2019-2025 | Skyrizi, Rinvoq |
| Regeneron Healthcare Solutions, INC. | $314.33 | 2019-2025 | Libtayo |
| Lilly USA, LLC | $215.87 | 2020-2025 | Taltz, Ebglyss, Olumiant |
| E.R. Squibb & Sons, L.L.C. | $149.82 | 2023 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $147.96 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $145.72 | 2019-2024 | |
| Dermira, INC. | $125.00 | 2019 | |
| Biofrontera INC. | $119.33 | 2019 | |
| Genentech USA, INC. | $54.47 | 2022-2024 | Erivedge |
| Strata Skin Sciences, INC. | $44.27 | 2019-2025 | Xtrac |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $32.52 | 2020 | |
| Amgen INC. | $24.27 | 2019 | |
| Genzyme Corporation | $23.67 | 2022 | |
| Dusa Pharmaceuticals, INC. | $22.21 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $18.61 | 2023 | |
| Epi Health, LLC | $18.25 | 2019-2020 | |
| Leo Pharma INC. | $15.01 | 2019 | |
| Merck Sharp & Dohme LLC | $14.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Coleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.